AUDUBON, Pa., Nov. 03, 2026 (GLOBE NEWSWIRE) --

宾夕法尼亚州奥杜邦，2026年11月3日（环球电讯社）--

Globus Medical, Inc.

Globus Medical, Inc.

a leading musculoskeletal technology company, today announced that it completed the acquisition of Synaptive Medical, deepening the Company's presence in cranial neurosurgery and positioning it for further growth in this market.

一家领先的肌肉骨骼技术公司今日宣布，已完成对Synaptive Medical的收购，从而加深公司在颅神经外科领域的布局，并为在该市场的进一步增长奠定基础。

Synaptive Medical

Synaptive Medical

is a medical technology company focused on developing solutions for complex cranial procedures, with technologies spanning surgical visualization, navigation, surgical planning, and MRI. The acquisition completed on August 4, 2026, through a court-appointed receivership process, adds to Globus Medical's portfolio of enabling technologies for neurosurgery..

是一家专注于为复杂颅脑手术开发解决方案的医疗技术公司，其技术涵盖手术可视化、导航、手术规划以及磁共振成像（MRI）。该公司于2026年8月4日通过法院指定的接管程序完成收购，此举进一步丰富了Globus Medical在神经外科赋能技术方面的产品组合。

'This acquisition builds on the foundation we have established in cranial neurosurgery and accelerates our growth in this important market,'

“此次收购在我们已建立的颅神经外科基础之上，进一步加速了我们在这一重要市场的增长。”

said

说

Keith Pfeil, President and Chief Executive Officer of Globus Medical

Keith Pfeil，Globus Medical 总裁兼首席执行官

.

。

'Synaptive brings proven surgical planning and visualization technology, as well as relationships with leading neurosurgical centers, and we see a clear opportunity to combine these solutions with our enabling technology expertise to serve more neurosurgeons and their patients.'

“Synaptive 带来了经过验证的手术规划和可视化技术，以及与领先神经外科中心的合作关系。我们认为，将这些解决方案与我们的赋能技术专业专长相结合，能够为更多神经外科医生及其患者提供服务，这其中存在明确的机遇。”

Globus Medical's immediate priority is continuity for Synaptive customers. The Company has begun outreach to customers and stakeholders and is establishing service and support for the installed base, as it finalizes its long-term commercial strategy for the business.

Globus Medical 的首要任务是确保 Synaptive 客户的业务连续性。公司已开始与客户及利益相关方接洽，并为已安装设备建立服务与支持体系，同时最终确定该业务的长期商业战略。

Looking ahead, the acquisition enhances Globus Medical's presence in cranial neurosurgery and creates opportunities to further develop integrated procedural solutions that combine surgical visualization, navigation and planning with the Company’s Excelsius ecosystem of enabling technologies.

展望未来，此次收购将增强Globus Medical在颅神经外科领域的地位，并创造机会，进一步开发将手术可视化、导航和规划与公司的Excelsius赋能技术生态系统相结合的集成化手术解决方案。

About Globus Medical, Inc.

关于Globus医疗公司

Globus Medical, Inc. is a leading global musculoskeletal technology company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials, and enabling technologies.

Globus Medical, Inc. 是一家全球领先的肌肉骨骼技术公司，致力于解决尚未满足的临床需求并改善患者生活。我们以充满激情的紧迫感推动创新，提供世界一流的教育和临床支持，并在脊柱、骨科创伤、关节重建、生物材料以及赋能技术领域不断推进医疗护理的发展。

Additional information can be accessed at www.globusmedical.com..

更多信息请访问 www.globusmedical.com。

Safe Harbor Statements

安全港声明

All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms.

本新闻稿中除历史事实陈述外的所有陈述均为前瞻性陈述，可通过使用“相信”、“可能”、“或许”、“能够”、“将”、“旨在”、“估计”、“继续”、“预见”、“打算”、“预期”、“计划”及其他类似词语来识别。

These forward-looking statements are based on our current assumptions, expectations, and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties, and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted.

这些前瞻性陈述基于我们对未来事件和趋势的当前假设、预期和估计。前瞻性陈述仅为预测，受多种风险、不确定性和其他因素的影响，这些因素可能影响我们的业务和运营，并可能导致实际结果与预测结果存在重大差异。

These risks and uncertainties include, but are not limited to, the risks and costs associated with health epidemics, pandemics, and similar outbreaks, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, the successful integration of businesses that we have acquired or may acquire in the future, and other risks.

这些风险和不确定性包括但不限于：与健康流行病、大流行病及类似疫情相关的风险和成本；影响我们季度业绩的因素；我们管理增长的能力；我们维持盈利的能力；对我们产品的需求；我们成功竞争的能力（包括但不限于说服外科医生使用我们产品的能力，以及吸引和留住销售人员及其他员工的能力）；我们快速开发并推出新产品的能力；我们制定并执行成功商业战略的能力；我们遵守当前或未来可能适用于我们业务的法律法规的能力；我们保护知识产权的能力；我们在应对针对我们的法律诉讼中的抗辩成功与否；医疗器械行业的趋势；总体经济状况；对我们已收购或未来可能收购的企业的成功整合；以及其他风险。

For a discussion of these and other risks, uncertainties, and other factors that could affect our results, refer to the disclosu.

有关可能影响我们业绩的上述及其他风险、不确定性和其他因素的讨论，请参阅披露内容。

Contact:

联系方式：

Shagun Singh

沙贡·辛格

Senior Vice President, Strategy and Investor Relations

战略与投资者关系高级副总裁

Phone: (610) 930-1800

电话：(610) 930-1800

Email: investors@globusmedical.com |

邮箱：investors@globusmedical.com |

www.globusmedical.com

www.globusmedical.com